Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
for
Cystic Fibrosis
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 18 - 45
Code: NCT06163482
Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Cincinnati OH, Columbus OH, Louisville KY, Detroit MI,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase2, Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Location: Cincinnati OH, Columbus OH, Maumee OH, St Louis MO,
Sponsor: Tempus AI
Sex: All
Age: 0+
Code: NCT07154823
Recruiting
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Cincinnati OH, London, Baltimore MD, Philadelphia PA,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase3, Recruiting
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
for
CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia,
Location: Cincinnati OH
Sponsor: Zulfa Omer
Sex: All
Age: 18+
Code: NCT07108998
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma,
Location: Cincinnati OH
Sponsor: Zulfa Omer
Sex: All
Age: 18+
Code: NCT07014917
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
for
Depressive Disorder, Major
Location: Cincinnati OH, Evanston IL, Washington D.C. DC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 12 - 17
Code: NCT07227454
Phase3, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Cincinnati OH, Columbus OH, Lexington KY, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)